Combined bottle and cap
Latest Bristol-Myers Squibb Company Patents:
- Synthetic options towards the manufacture of (6R,10S)-10-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6H)-pyrimidinyl} - 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-one
- Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof
- Supramolecular filamentous assemblies for protein purification
- Classifying documents using a domain-specific natural language processing model
- COMBINATION THERAPY OF KRAS INHIBITOR AND TREG DEPLETING AGENT
Description
FIG. 1 is a perspective view of our new design of a combined bottle and cap;
FIG. 2 is a top plan view thereof;
FIG. 3 is a front elevation view thereof;
FIG. 4 is a side elevational view thereof, the undisclosed opposite side being a mirror image;
FIG. 5 is a rear elevational view thereof; and,
FIG. 6 is a bottom plan view thereof.
Referenced Cited
Patent History
Patent number: D403592
Type: Grant
Filed: Jul 14, 1997
Date of Patent: Jan 5, 1999
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventors: Joseph M. Everard (Fairfield, CT), Sara Hendelman-Schorer (New York, NY)
Primary Examiner: Lucy Lieberman
Attorney: Anthony M. Santini
Application Number: 0/73,532
Type: Grant
Filed: Jul 14, 1997
Date of Patent: Jan 5, 1999
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventors: Joseph M. Everard (Fairfield, CT), Sara Hendelman-Schorer (New York, NY)
Primary Examiner: Lucy Lieberman
Attorney: Anthony M. Santini
Application Number: 0/73,532
Classifications
Current U.S. Class:
D/9542;
D9/449
International Classification: 0901;
International Classification: 0901;